Echinococcus granulosus antigen B ameliorates myocardial infarction through promoting M2 macrophage polarization
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1662758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Weixiao Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: First Affiliated Hospital of Bengbu Medical University, Bengbu, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Macrophages, Echinococcus granulosus, Antigens, Helminth. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Myocardial infarction (MI) is a severe cardiovascular condition arising from a sudden reduction or complete cessation of blood supply via the coronary arteries, resulting in localized necrosis of the corresponding myocardial tissue due to persistent ischemia and hypoxia. It is a life-threatening cardiovascular disease with high death rate and poor prognosis due to myocardial necrosis. Echinococcus granulosus hydatid cyst-secreted antigen B ( Eg AgB) has been shown to play a critical role in modulating host immune responses. This study aims to investigate whether the Eg AgB subunit 8 ( Eg AgB8/2) is able to mitigate inflammation associated with myocardial infarction and therefore reduce the MI caused mortality in a mouse model,. The MI model was established by ligating the left anterior descending (LAD) coronary artery in male C57BL/6J mice, followed by intraperitoneal administration of recombinant Eg AgB subunit 2 (r Eg AgB8/2) to observe its therapeutic effect on MI and related immunological mechanism. To evaluate the role of r Eg AgB8/2 in macrophage polarization post-MI, mRNA levels of M1 macrophage marker iNOS and M2 marker Arg-1 were determined in infarcted regions using RT-qPCR. In vitro , RAW264.7 macrophages were co-incubated with rEgAgB8/2 and observe whether r Eg AgB8/2 is able to promote M2 macrophage polarization under inflammation condition.
Results
Our study in a MI mouse model demonstrated that treatment with r Eg AgB8/2 significantly improved cardiac function and survival rates from 66.7% to 94.4% within 28 days post MI surgery compared to MI group without treatment. The levels of pro-inflammatory cytokines TNF-α and IL-1β were significantly reduced in infarcted region in heart tissue and serum, while regulatory cytokines IL-10 and TGF-β were increased following r Eg AgB8/2 treatment associated with reduced expression of M1 macrophage marker iNOS and increased expression of the M2 macrophage marker Arg-1. The treatment of r Eg AgB8/2 downregulated NLRP3, caspase-1, and IL-1β protein levels in infarcted tissues. In vitro study with macrophage cell line RAW264.7 further demonstrated that co-incubation of r Eg AgB8/2 with LPS-induced RAW264.7 cells resulted in a decrease in the proportion of CD86 + macrophages (M1) and an increase in the proportion of CD206 + macrophages (M2) associated with reduced inflammatory cytokines (TNF-α and IL-1β) and increased regulatory cytokines (IL-10 and TGF-β), which was consistent with the results obtained from the in vivo experiments in a MI mouse model.
Conclusions
These findings reveal that r Eg AgB8/2 ameliorates MI in mice by promoting macrophage polarization from M1 to M2 phenotypes through inhibition of the NLRP3/caspase-1/IL-1β signaling pathway, indicating its potential as a therapeutic agent for MI and other inflammation-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
- Anhui Key Laboratory of Infection and Immunity of Bengbu Medical University, Bengbu, China.
- Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
- Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
- National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.
- Scientific Research Center, Bengbu Medical University, Anhui, Bengbu, China.
Zitieren
APA
Zhang, W., Liu, B., Wang, S., Xu, X., Jin, Q., Yang, C., Wang, H., Gao, E., Zhan, B., Wu, S., Wang, R., Zhou, R., & Yang, X. (2025). Echinococcus granulosus antigen B ameliorates myocardial infarction through promoting M2 macrophage polarization. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1662758
Vancouver
Zhang W, Liu B, Wang S, Xu X, Jin Q, Yang C, et al. Echinococcus granulosus antigen B ameliorates myocardial infarction through promoting M2 macrophage polarization. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1662758
BibTeX
@article{Zhang2025,
author = {Zhang, Weixiao and Liu, Bingxin and Wang, Sai and Xu, Xinlong and Jin, Qiwang and Yang, Chen and Wang, Hui and Gao, Erhe and Zhan, Bin and Wu, Shili and Wang, Rui and Zhou, Rui and Yang, Xiaodi},
title = {Echinococcus granulosus antigen B ameliorates myocardial infarction through promoting M2 macrophage polarization},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1662758}
}
EUVIMED